Skip to main content

Find Clinical Trials

Home
Conditions
B-cell Lymphoma Refractory

Clinical trial condition

B-cell Lymphoma Refractory

Explore clinical trials studying B-cell Lymphoma Refractory. Study availability and eligibility vary by location and protocol.

13 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

B-cell Lymphoma Refractory trial results

Completed

MB-CART20.1 Lymphoma

NCT03664635

Conditions: B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
Locations: University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany

Universitätsklikum Leipzig, AöR Leipzig, Germany

View Trial Details

Completed

CAR T Cell Therapy Related Cardiovascular Outcomes

NCT05130489

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +30 more
Locations: University College London Hospitals London, United Kingdom

View Trial Details

Completed

Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma

NCT01535989

Conditions: B-cell Lymphoma Refractory
Locations: InselSpital, Universitätsspital Bern Bern, Canton of Bern, Switzerland

Oncology Institute of Southern Switzerland Bellinzona, Canton Ticino, Switzerland

Kantonsspital St.Gallen San Gallen, Switzerland

View Trial Details